Brokering and Accelerating Life-Science Innovation
PharmNovaTechBridge (PNTB) connects pharma, medtech, CBRN, and investors to transform cutting-edge research into global impact
Connecting Innovation With Impact
PharmNovaTechBridge (PNTB) transforms breakthrough science into real-world solutions. We bridge the gap between research, industry, and investment - accelerating innovation across pharma, medtech, veterinary, and defense.
We are scientists, entrepreneurs, and strategists with a clear mission: to unlock underused assets, support new discoveries, and deliver them to markets where they make the greatest difference. Our core values - trust, precision, and forward vision - shape every partnership we build.
From Discovery to Deployment
At PNTB, we combine deep scientific expertise with strategic market insight. Our work spans early-stage research, product development, and deal brokering - enabling breakthroughs in pharma, medtech, veterinary, CBRN, and longevity. We leverage advanced technologies, strong networks, and disciplined execution to turn innovation into impact.
1
Pharma
6 ONGOING PROJECTS
We scout, broker, and selectively develop pharmaceutical assets — from niche molecules to orphan drugs — bridging early innovation with global pharma markets.
2
Veterinary
5 ONGOING PROJECTS
Supporting animal health with innovative therapies, diagnostics, and supplements. We enable veterinary-focused companies to expand across Europe and beyond.
3
CBRN
3 ONGOING RESEARCH PROJECTS
Partnering with defense and government stakeholders to supply pharmaceuticals, medtech, and countermeasure solutions tailored to operational needs.
1
Drug Development
4 ONGOING PROJECTS
Full lifecycle of pharmaceutical innovation (both human and veterinary) – from target validation and preclinical studies to clinical development, regulatory strategy, production and distribution – to accelerate safe and effective therapies to market.
2
Medical Devices & Diagnostics Development
3 ONGOING PROJECTS
Supporting animal health with innovative therapies, diagnostics, and supplements. We enable veterinary-focused companies to expand across Europe and beyond.
3
CBRN
1 ONGOING PROJECT
Providing expertise in Chemical, Biological, Radiological, and Nuclear defense – from toxicology and risk assessment to countermeasure development. We bridge science, policy, and practice to strengthen preparedness and resilience against CBRN threats.
4
Longevity
2 ONGOING PROJECTS
Advancing science and innovation to extend healthy human lifespan – from molecular research and biomarker discovery to preventive medicine, nutrition, and advanced therapeutics. Our mission is to translate cutting-edge longevity research into real-world health solutions.
5
Food supplements & Nutrition
4 ONGOING PROJECTS
Developing and validating innovative nutritional products and dietary supplements – from bioactive compounds and functional foods to clinical evaluation and regulatory support. Our goal is to bridge evidence-based nutrition with real-world health benefits.
At PharmNovaTechBridge, we believe the future of healthcare and technology depends on collaboration. We stand for advancing science responsibly, bridging research with real-world applications, and creating solutions that improve human and animal health while strengthening global resilience.
Kristian Lorenc
CEO and Co-Founder of PNTB
Kamil Kuca
CSO and Co-founder of PNTB
